CRISPR and Cas Genes Market Revenue 2024 to 2034
CRISPR and Cas Genes Market Revenue 2024 to 2034
The CRISPR & Cas genes market is set to expand from USD 4.68 Bn in 2024 to USD 22.30 Bn by 2034, at a strong 16.9% CAGR, driven by breakthroughs in gene editing, personalized medicine, and therapeutic innovations.
Report ID: 10535
|
Format: Databook
|
Published: August 2025
|
Delivery: Immediate
Download Sample
Customisation Request
Revenue,
USD 4.68 Bn
Forecast Year,
USD 22.30 Bn
CAGR, 2025 -
16.90%
Report Coverage
Worldwide
Reviewed By
Aditi Shivarkar
Reviewed By
Aman Singh
CRISPR and Cas Genes Market Size Analysis
CRISPR and Cas Genes Market Size By Product & Service 2024 to 2034 (USD )
| Product & Service | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Kits & Reagents | 2.15 | 2.54 | 2.99 | 3.52 | 4.15 | 4.89 | 5.76 | 6.79 | 8.00 | 9.43 | 11.11 |
| Tools/Enzymes/Plasmids | 0.94 | 1.09 | 1.26 | 1.46 | 1.70 | 1.97 | 2.29 | 2.66 | 3.08 | 3.58 | 4.15 |
| Services | 1.03 | 1.19 | 1.39 | 1.61 | 1.87 | 2.16 | 2.51 | 2.91 | 3.37 | 3.91 | 4.53 |
| Others | 0.56 | 0.65 | 0.76 | 0.88 | 1.02 | 1.19 | 1.38 | 1.60 | 1.86 | 2.16 | 2.51 |
CRISPR and Cas Genes Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biomedical | 3.37 | 3.95 | 4.64 | 5.45 | 6.39 | 7.51 | 8.81 | 10.34 | 12.14 | 14.25 | 16.72 |
| Agricultural | 0.84 | 0.98 | 1.14 | 1.32 | 1.53 | 1.78 | 2.07 | 2.40 | 2.79 | 3.24 | 3.76 |
| Others | 0.47 | 0.54 | 0.62 | 0.71 | 0.81 | 0.93 | 1.06 | 1.22 | 1.39 | 1.59 | 1.82 |
CRISPR and Cas Genes Market Size By End-use 2024 to 2034 (USD )
| End-use | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotech & Pharma | 2.53 | 2.97 | 3.48 | 4.09 | 4.80 | 5.63 | 6.61 | 7.75 | 9.10 | 10.68 | 12.54 |
| Academic/Research | 1.78 | 2.08 | 2.42 | 2.83 | 3.30 | 3.85 | 4.50 | 5.25 | 6.13 | 7.15 | 8.35 |
| Others | 0.37 | 0.43 | 0.49 | 0.56 | 0.64 | 0.73 | 0.84 | 0.96 | 1.09 | 1.24 | 1.41 |
CRISPR and Cas Genes Market Size By Region 2024 to 2034 (USD )
| Region | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 1.68 | 1.97 | 2.30 | 2.68 | 3.13 | 3.66 | 4.27 | 4.98 | 5.82 | 6.79 | 7.93 |
| Europe | 1.31 | 1.53 | 1.79 | 2.09 | 2.44 | 2.85 | 3.34 | 3.90 | 4.55 | 5.32 | 6.22 |
| Asia Pacific | 1.36 | 1.60 | 1.89 | 2.23 | 2.63 | 3.11 | 3.67 | 4.33 | 5.10 | 6.02 | 7.11 |
| Latin America | 0.19 | 0.21 | 0.23 | 0.25 | 0.28 | 0.30 | 0.33 | 0.35 | 0.37 | 0.39 | 0.41 |
| Middle East & Africa | 0.14 | 0.16 | 0.19 | 0.22 | 0.26 | 0.30 | 0.35 | 0.41 | 0.47 | 0.55 | 0.64 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com
